Yesterday, Sept. 15, 2015, 72 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $35.04 to $4,142,629.75.

Highlighted Stocks Traded by Insiders:

WellCare Health Plans (WCG) - FREE Research Report

Hickey Kevin F, who is Director at WellCare Health Plans, sold 2,088 shares at $96.43 on Sept. 15, 2015. Following this transaction, the Director owned 17,076 shares meaning that the stake was reduced by 10.9% with the 2,088-share transaction.

The shares most recently traded at $96.70, up $0.27, or 0.28% since the insider transaction. Historical insider transactions for WellCare Health Plans go as follows:

  • 4-Week # shares sold: 1,000
  • 12-Week # shares sold: 1,000
  • 24-Week # shares sold: 5,000

The average volume for WellCare Health Plans has been 408,100 shares per day over the past 30 days. WellCare Health Plans has a market cap of $4.2 billion and is part of the health care sector and health services industry. Shares are up 20.05% year-to-date as of the close of trading on Tuesday.

WellCare Health Plans, Inc. provides managed care services for government-sponsored health care programs. It operates in three segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. The company has a P/E ratio of 44.3. Currently, there are 3 analysts who rate WellCare Health Plans a buy, 2 analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on WCG - FREE

TheStreet Quant Ratings rates WellCare Health Plans as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, good cash flow from operations, increase in net income and solid stock price performance. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full WellCare Health Plans Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

ConnectOne Bancorp (CNOB) - FREE Research Report

Boswell Stephen T., who is Director at ConnectOne Bancorp, bought 5,000 shares at $18.97 on Sept. 15, 2015. Following this transaction, the Director owned 258,437 shares meaning that the stake was boosted by 1.97% with the 5,000-share transaction.

The shares most recently traded at $19.00, up $0.03, or 0.16% since the insider transaction. Historical insider transactions for ConnectOne Bancorp go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 12,000
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 12,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 12,000

The average volume for ConnectOne Bancorp has been 103,100 shares per day over the past 30 days. ConnectOne Bancorp has a market cap of $571.2 million and is part of the financial sector and banking industry. Shares are unchanged year-to-date as of the close of trading on Tuesday.

ConnectOne Bancorp, Inc. operates as the bank holding company for ConnectOne Bank that provides various banking products and services. The stock currently has a dividend yield of 1.58%. The company has a P/E ratio of 20.0. Currently, there are 3 analysts who rate ConnectOne Bancorp a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNOB - FREE

TheStreet Quant Ratings rates ConnectOne Bancorp as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, compelling growth in net income, growth in earnings per share, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full ConnectOne Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mead Johnson Nutrition (MJN) - FREE Research Report

Clark Clesteen A, who is Director at Mead Johnson Nutrition, bought 500 shares at $76.05 on Sept. 15, 2015. Following this transaction, the Director owned 8,610 shares meaning that the stake was boosted by 6.17% with the 500-share transaction.

The shares most recently traded at $75.24, down $0.81, or 1.07% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 2,263
  • 12-Week # shares bought: 22,000
  • 12-Week # shares sold: 2,263
  • 24-Week # shares bought: 22,000
  • 24-Week # shares sold: 17,263

The average volume for Mead Johnson Nutrition has been 2.2 million shares per day over the past 30 days. Mead Johnson Nutrition has a market cap of $15.2 billion and is part of the consumer goods sector and food & beverage industry. Shares are down 24.61% year-to-date as of the close of trading on Tuesday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 2.2%. The company has a P/E ratio of 21.4. Currently, there are 4 analysts who rate Mead Johnson Nutrition a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition as a buy. The company's strengths can be seen in multiple areas, such as its expanding profit margins, good cash flow from operations and notable return on equity. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Mead Johnson Nutrition Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.